Navigation Links
Arpida Announces Agenda Items for Shareholders Meeting
Date:4/15/2008

REINACH, Switzerland, April 15 /PRNewswire-FirstCall/ -- Arpida Ltd. (SWX: ARPN) today published the agenda for the Annual General Meeting of Shareholders, to be held in Basel on 7 May 2008. The invitation appears today in several Swiss media and will be sent to all registered Arpida shareholders. The agenda is available on the website http://www.arpida.com.

Apart from the yearly recurring agenda items, Arpida's Board of Directors will put two additional proposals to the shareholders.

The first additional agenda item relates to the proposed appointment of Elmar Schnee to the Board of Directors.

Elmar Schnee is a highly experienced Pharma executive who has gathered a wealth of international experience at several large and small pharmaceutical companies. He is currently President of Merck Serono S.A. and Regular Member of the Executive Board and General Partner of Merck KGaA, with responsibility for the Pharmaceuticals business sector. Mr Schnee is a Swiss national.

The terms of three current Arpida Board members expire in the AGM of 7 May 2008 and all three will stand for re-election. Professor Nam-Hai Chua, a Board member since 2004, has resigned from the Board.

The second additional proposal is aimed at increasing Arpida's flexibility in terms of potential financing instruments. In the past, Arpida's funds have primarily been provided by equity investors through the issue of shares. Going forward, Arpida may consider alternative sources of funding such as, for instance, convertible bonds.

In order to create the possibility to issue such instruments, the Company will ask its shareholders to make the necessary changes to its Articles of Association. If the shareholders' meeting approves these changes, Arpida will have the possibility to issue a total of no more than 3.2 million shares (15% of the currently outstanding share capital), either via a straight equity issue (
'/>"/>

SOURCE Arpida Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Arpida Submits New Drug Application for Intravenous Iclaprim for Treatment of Skin Infections
2. Arpida Announces Full Year 2007 Financial Results
3. Arpida Provides Update on Progress of New Drug Application for Intravenous Iclaprim
4. Arpida Reports Progress in Pivotal Phase III Trial With TLT Treatment in Onychomycosis
5. Arpida Receives Green Light From US FDA for Phase II Efficacy Trial With Oral Iclaprim
6. Arpida-Supported CME Symposium Available Online
7. Arpida Presents Data on Iclaprim at Scientific Congress in Germany
8. Arpida Presents Preclinical Data on AR-2474 at ICAAC
9. Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC
10. Arpida Invited to Present Preclinical Data on Novel Topical Antibiotic AR-2474 at ICAAC
11. Arpida Interim Results for six Months to 30 June 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ELLYN, Ill. , July 2, 2015 ... Colton Eakins are gaining invaluable real-world experiences ... of Technology this summer. The students will ... Dr. Jeff Wereszczynski,s research group at IIT. The ... Dr. Tom Carter , Physics; Dr. Kathy ...
(Date:7/2/2015)... ... 2015 , ... In’Tech Medical SAS ( http://www.intech-medical.com ), a ... the acquisition of Turner Medical, Inc ., thus becoming a global leader ... Spine Industry. The acquisition of Turner Medical ideally supplements In’Tech Medical’s product offering, ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... The next-generation ... several key market segments, including the molecular diagnostics industry. BCC Research reveals in its ... of NGS-based tests, lower test costs, and a growing need for better diagnostics as ...
(Date:7/1/2015)... Ariz. , July 1, 2015 Isagenix ... it has earned three Gold, three Silver, and three ... Awards gala held in Chicago ... as the premier business awards program in the U.S. ... recognizes our company,s strength in developing leaders, cultivating talent, ...
Breaking Biology Technology:COD Students Participate in Prestigious Summer Internships 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3Isagenix Earns Nine American Business Awards 2Isagenix Earns Nine American Business Awards 3
... Mass. and TORONTO, Sept. 16, 2011 Generex ... today that Dr. Nicola Napolii, from University Campus ... of the clinical data on Generex Oral-lyn™ buccal ... European Association for the Study of Diabetes (EASD) ...
... (NASDAQ: AMGN ) will participate in the UBS ... the Grand Hyatt in New York City, beginning at 8:30 ... president of Research and Development at Amgen, will present at ... from the Events Calendar on Amgen,s website, www.amgen.com , ...
... for Brain Science announced today the discovery of a new ... neural stem cells, offering a fresh avenue in the search ... published collaborative study, authored by scientists from the University of ... Montreal Neurological Institute and Hospital at McGill University and titled ...
Cached Biology Technology:Generex Makes Podium Presentation of Clinical Data on Generex Oral-lyn™ at European Association for the Study of Diabetes Annual Meeting 2Generex Makes Podium Presentation of Clinical Data on Generex Oral-lyn™ at European Association for the Study of Diabetes Annual Meeting 3Generex Makes Podium Presentation of Clinical Data on Generex Oral-lyn™ at European Association for the Study of Diabetes Annual Meeting 4New Class of Stem Cell-Like Cells Discovered in Spinal Cord Offers Possibilities for Spinal Cord Repair 2New Class of Stem Cell-Like Cells Discovered in Spinal Cord Offers Possibilities for Spinal Cord Repair 3
(Date:6/30/2015)... , June 30, 2015 To bolster its efforts ... HYPR Corp. announced today the addition of two new team ... as board advisor and David Raviv will act ... underscore HYPR Corp.,s commitment to providing the most secure solutions ... Sirota co-founded Layer 7 Technologies, a provider of security ...
(Date:6/26/2015)... Utah , June 26, 2015 ATL Technology, ... and devices with specialties in single use solutions, headquartered in ... of MedConx, Inc. (a California corporation ... and San Jose, Costa Rica ). ... Costa Rica with ATL Technology,s existing facility ...
(Date:6/25/2015)...  TAKE Solutions Ltd., a global business technology solutions ... Patent and Trademark Office (USPTO) for its "Method for ... Clinical Accelerators to reduce the time taken to standardize ... without the accelerators), thus reducing time to market. ... the heart of the patented Clinical Data Standardization Process ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2TAKE Solutions Awarded Patent By USPTO 2
... may contribute to increased productivity in sustainable agriculture, according ... issue of the journal Science. The study analyzes, ... experiments all over the world, involving corn and cotton ... properties. The research was conducted by scientists at ...
... water could provide an early indicator of climate change. ... could forewarn of climate change in 10 to 20 ... Science Foundation (ESF) conference, scientists predicted that the waters ... New Zealand are the places to watch. , Palaeoclimate ...
... million people worldwide were estimated to be living with Alzheimer’s ... at the Johns Hopkins Bloomberg School of Public Health. The ... grow to more than 106 million by 2050. By that ... high-level care, equivalent to that of a nursing home. The ...
Cached Biology News:New study finds genetically engineered crops could play a role in sustainable agriculture 2Salty oceans provide early warning for climate change 2Alzheimer's disease to quadruple worldwide by 2050 2
... XIII in both reduced and non-reduced forms. It ... or human Factor XII. Factor XIII is a ... two subunits. Factor XIII-A is the catalytic subunit ... XIII is present in plasma as an Alpha2Beta2 ...
... Anti-Lipid Phosphate Phosphatase 2 ... buffered aqueous solution ... saline containing 0.08% sodium ... from the human LPP2 ...
Anti-CaM kinase II recognizes the enzymes a subunit (6) and reacts with tissue from all mammalian species tested, as well as with chicken and frog tissues....
... Anti-MAPKAPK-2, Phospho-Specific(Thr 222 ) ... NaCl, 10 mM sodium HEPES, ... pH 7.5. Recognizes the ~47 ... 2 (MAPKAPK-2) protein phosphorylated at ...
Biology Products: